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Abstract
Background—Maternal inflammation during pregnancy increases risk for offspring psychiatric 
disorders and other adverse long-term health outcomes. The influence of inflammation on the 
developing fetal brain is hypothesized as one potential mechanism, but has not been examined in 
humans.
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Methods—Participants were N=86 adult women recruited in early pregnancy, and their infants 
born after 34-weeks gestation. A biological indicator of maternal inflammation (interleukin-6 
[IL-6]), which has been shown to influence fetal brain development in animal models, was 
quantified serially in early, mid and late pregnancy. Structural and functional brain MRI was 
acquired in neonates shortly after birth. Infants’ amygdalae were individually segmented for 
measures of volume and as seeds for resting state functional connectivity. At 24-months-of-age, 
children completed a snack delay task to assess impulse control.
Results—Higher average maternal IL-6 concentration during pregnancy was prospectively 
associated with larger right amygdala volume and stronger bilateral amygdala connectivity to brain 
regions involved in sensory processing and integration (fusiform, somatosensory cortex, 
thalamus), salience detection (anterior insula), and learning and memory (caudate and 
parahippocampal gyrus). Larger newborn right amygdala volume and stronger left amygdala 
connectivity were in turn associated with lower impulse control at 24-months-of-age, and 
mediated the association between higher maternal IL-6 concentrations and lower impulse control.
Conclusions—These findings provide new evidence in humans linking maternal inflammation 
during pregnancy with newborn brain and emerging behavioral phenotypes relevant for psychiatric 
disorders. A better understanding of intrauterine conditions that influence offspring disease 
susceptibility is warranted to inform targeted early intervention and prevention efforts.
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Introduction
Maternal inflammation during pregnancy appears to increase risk for offspring 
neuropsychiatric disorders and adverse physical health outcomes.(1–3) Strong 
epidemiological evidence identifies connections between common conditions associated 
with heightened inflammation during pregnancy, including infection,(4–15) high maternal 
body mass index (BMI)(16–18), maternal psychopathology(19), increased psychosocial 
stress,(20) and elevated risk for offspring developing schizophrenia, autism, attention-deficit 
hyperactivity disorder (ADHD)(21) and other neurological and psychiatric disorders(12). 
Thus, maternal inflammation during pregnancy is a strong candidate for mediating effects of 
diverse conditions on offspring neurodevelopment with implications for long-term health. 
However, to our knowledge, the influence of maternal inflammation during pregnancy on 
developing brain systems implicated in psychiatric disorders has not yet been examined in 
humans.
Animal models support a key role for cytokines, inflammatory signaling proteins, as sensors, 
transducers, and effectors of environmental conditions on the developing embryonic and 
fetal brain. Maternal pro-inflammatory cytokine levels are elevated across a range of diverse 
high-risk conditions (sensors),(20, 22, 23) with accompanying increases in pro-
inflammatory cytokines in placental tissue, amniotic fluid and the fetal brain (transducers).
(24–27) Cytokines are also expressed in the fetal brain as part of typical neurodevelopmental 
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processes,(28) and facilitate cellular survival, proliferation and differentiation, axonal 
growth and synaptogenesis.(29–32) Elevated cytokine levels in the fetal brain (such as in 
response to maternal inflammation) trigger alterations in these aspects of 
neurodevelopment(33–35) (effectors). Interleukin-6 (IL-6), a pro-inflammatory cytokine,
(36) exemplifies this tripartite role. Heightened IL-6 concentrations are evident across 
various maternal gestational conditions (e.g., obesity, psychosocial stress, depression and 
infection) that, in turn, have been shown to increase susceptibility for psychiatric disorders 
in offspring.(15, 20, 37, 38) Administration of IL-6 to pregnant dams mimics effects of 
maternal immune activation on upregulation of genes implicated in autism and 
schizophrenia in fetal brain tissue.(39) Moreover, effects of maternal immune activation on 
inflammation and gene expression in the fetal brain, and subsequent behavioral deficits, are 
eliminated by blocking IL-6 in the pregnant dam(40), or the placenta(41). Thus, examination 
of maternal IL-6 in relation to human fetal brain development represents an important step 
towards elucidating pathways by which maternal inflammation during pregnancy influences 
offspring risk for psychiatric disorders.
The present study seeks to advance understanding in this area by examining associations 
between systemic maternal IL-6 concentrations during pregnancy, newborn amygdala 
volume and functional connectivity, and emerging behavioral phenotypes at 24-months-of-
age. The amygdala is of specific interest due to the relevance for offspring phenotypes 
associated with heightened maternal inflammation during pregnancy in animal models, 
including social deficits, increased emotional and stress reactivity (26, 42–44), heightened 
aggression (45), and decreased appetitive control(46, 47). Moreover, psychiatric disorders 
linked to maternal inflammation during pregnancy (e.g. schizophrenia, autism and ADHD) 
are also characterized by social deficits, and difficulty regulating emotions and behaviors.
(15, 48–50) Alterations in amygdala integrity identified at the onset of these disorders 
suggest a potential causal role in pathogenesis(51, 52). Lastly, evidence that maternal 
inflammation during pregnancy enhances risk for psychiatric disorders by sensitizing 
offspring to adverse postnatal events (e.g. "a second hit"(15, 53)), further implicates stress 
sensitive brain regions, such as the amygdala.
The capacity to control impulses in service of working towards a goal, also referred to as 
inhibitory or effortful control, is foundational for regulating emotions and behaviors.(54–56) 
Impulse control can already be measured reliably during toddlerhood,(57, 58) and predicts 
subsequent behavioral, emotional and health outcomes during childhood(57, 59–61), 
adolescence(62) and adulthood(63). Difficulty regulating emotions and behaviors is a 
common feature across psychiatric disorders linked to maternal inflammation during 
pregnancy. We therefore examine impulse control at 24-months-of-age as an early emerging 
indicator of the balance between children’s reactivity/impulsivity and regulatory capacity.
(64) We test whether aspects of newborn amygdala phenotypes linked to maternal IL-6 
concentrations during pregnancy also relate to children’s impulse control, to examine the 
relevance of alterations in the newborn amygdala for subsequent behavior. Further, we test 
whether maternal IL-6 concentrations during pregnancy relate to children’s impulse control 
via alterations in the newborn amygdala (statistical mediation).
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Mothers and children (N=86 with newborn structural MRI and N=70 with functional MRI 
data) were part of an ongoing, longitudinal study, conducted at the University of California, 
Irvine, for which mothers were recruited during the first trimester of pregnancy. 
Exclusionary criteria were as follows: maternal use of psychotropic medications or systemic 
corticosteroids during pregnancy; infant birth before 34 weeks gestation; and infant 
congenital, genetic, or neurologic disorder. Demographic characteristics are presented in 
Table 1 (N=86). A very small portion of mothers reported a mental health diagnosis at study 
entry (N=2). Behavioral data at 24-months-of-age (M=24.65 months, SD=.757) was 
available for a subset of children (N=52 with structural MRI and N=45 with functional MRI 
data). There were no significant differences in demographics for the full sample versus the 
sample with functional MRI data (N=70), or behavioral data. All procedures were approved 
by the Institutional Review Board at the University of California, Irvine, and written 
informed consent was obtained from all mothers.
Maternal Interleukin 6 (IL-6) concentrations
Maternal antecubital venous blood samples were collected in serum tubes in early, mid and 
late pregnancy (see Table 2). Serum IL-6 concentrations were determined using a 
commercial high sensitivity ELISA (eBioscience). See Supplementary Material for details. 
IL-6 concentrations (reported in Table 2) were significantly correlated across trimesters 
(r’s=0.55 to 0.68, p < .001), and were therefore averaged to form a composite of maternal 
IL-6 during pregnancy. The composite was base 2 logarithm transformed to bring outliers 
closer to the mean and normalize the distribution.
MRI and fMRI Data Acquisition and Processing
Data acquisition—Neuroimaging data was collected at approximately 4 weeks-of-age 
(M=3.79, SD=1.84) during natural sleep on a TIM Trio, Siemens 3.0T scanner. High 
resolution T2- (TR=3200ms, echo time=255ms, resolution=1×1×1mm, 4.18 mins) and T1-
weighted scans (MP-RAGE TR=2400ms, inversion time=1200ms, echo time=3.16ms, flip 
angle=8°, resolution=1×1×1mm, 6.18 mins) were collected. Images for resting state 
functional connectivity MRI (rs-fcMRI) were obtained using a gradient-echo, echoplanar 
imaging (EPI) sequence sensitive to blood oxygen level-dependent (BOLD) contrast 
(TR=2000ms; TE=30ms; FOV=220×220×160mm; flip angle=77°).
MRI and fMRI data preprocessing—Processing followed established procedures for 
neuroimaging with neonates as described in our previous work(65) and detailed in the 
Supplementary Materials. Briefly, brain images were separated from the rest of the head 
tissue, and functional images were preprocessed to reduce artifacts.(66) Atlas transformation 
involved calculation of a single matrix to facilitate registration to a standard infant template 
(0- to 2-month age range; MRI Study of Normal Brain Development)(67, 68), and to the 
Talairach coordinate system(69) (by aligning the infant template to a custom atlas-
transformed(70) target template [711-2B] using a series of affine transforms).(71)
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rs-fcMRI preprocessing—Additional preprocessing steps for rs-fcMRI were conducted 
to account for signal stemming from non-neuronal processes.(72, 73) These steps followed 
established procedures(73–75) including, temporal low-pass filtering (0 f < 0.1 Hz), 
regression of rigid body head motion parameters in 6 directions, regression of whole brain 
signal, regression of average ventricular signal, regression of white matter signal, and 
regression of first order derivative terms for the whole brain, ventricular, and white matter 
signals.(73–75) Volume censoring was employed to reduce effects of motion determined by 
framewise displacement (FD)(76) of .3mm. Remaining mean FD was subsequently 
examined as a potential confound (see Supplementary Materials).
Amygdala regions of interest—Amygdalae were individually segmented using a multi-
modality, multi-template based automatic method combining T1 and T2 weighted high-
resolution images,(77) followed by manual correction in ITK-Snap(78) (see Supplementary 
Materials). Mean volumes were 279.95mm3 (SD=31.59) and 270.55mm3 (SD=31.07) for 
right and left amygdala respectively. For rs-fcMRI analyses, amygdalae were transformed to 
atlas space based on the atlas transform previously computed. For volumetric analyses, 
amygdalae volumes were adjusted for intracranial volume (ICV) to account for differences 
in overall brain size.
Potential Confounds Relevant for Maternal IL-6 and Newborn Brain Outcomes
Potential confounds relevant to maternal inflammation and neurodevelopmental outcomes 
were examined to determine whether any identified associations between maternal IL-6 and 
the newborn amygdala could be better explained by other aspects of the prenatal 
environment. These included maternal pre-pregnancy body mass index (BMI), maternal 
cigarette smoking during pregnancy, obstetric (OB) risk, annual household income, and 
infant sex (see Supplementary Materials).
Impulse Control at 24-months-of-age
Impulse control was measured with the snack delay task.(79, 80) Children were instructed to 
wait until an experimenter rang a bell before eating a desired snack placed on the table in 
front of them. Four trials were conducted with each trial involving a longer wait time (10, 
15, 20 and 30 seconds). Scoring was consistent with the procedure established by Kochanska 
and colleagues,(79, 80) with higher scores indicative of waiting longer to reach for or eat the 
snack (i.e. better impulse control; see Supplementary Materials).
Attachment as an Indicator of the Postnatal Caregiving Environment
In examining the newborn amygdala in relation to impulse control at 24-months-of-age, it is 
important to consider the postnatal caregiving environment, which has been shown to 
influence development of regulatory skills(81–83). Children’s attachment security with their 
primary caregiver is indicative of the quality of caregiving, and the child’s capacity to use 
their caregiver to effectively regulate emotions and explore the environment.(84) Attachment 
was assessed with the well-established Strange Situation Paradigm (SSP)(84, 85) when 
children were 12-months-of-age. SSP administration and coding followed established 
procedures(85, 86) detailed in the Supplementary Materials. Analyses focused on a 
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dichotomous variable indicating secure (51.9%) versus insecure attachment classification 
(48,1%).
Analyses
Left and right amygdalae were examined separately due to evidence for lateralized effects of 
prenatal influences(87) and asymmetry in relation to psychiatric outcomes.(88) Mean 
maternal IL-6served as the independent variable, infant gestational age at birth (GA) and age 
at scan as covariates, and either amygdala volume or whole-brain voxel-wise connectivity as 
the dependent variable in regression models. For the rs-fcMRI analyses, multiple 
comparisons correction for p<0.05 voxel clusters required a threshold of 53 contiguous 
voxels with a Z-value> 2.25 based on Monte Carlo simulation(89)(see Supplementary 
Materials). Post-hoc analyses included mean maternal IL-6, infant GA at birth, age at scan, 
sex, mean remaining FD (for functional connectivity only), and all potential confounds 
entered together in the first step of a multiple regression model with the newborn amygdala 
phenotype as the dependent variable (see Supplementary Materials for further details). In the 
second step of the model, the moderating effect of infant sex was tested(90).
Newborn amygdala phenotypes which remained significantly associated with maternal IL-6 
after considering potential confounds, were examined in relation to impulse control. For 
functional connectivity, we only examined the strongest right and left amygdala connection 
associated with maternal IL-6 (based on Z-value) to reduce the number of statistical tests. 
We included a covariate for attachment status, and tested for interactive effects between the 
newborn amygdala phenotypes and attachment in predicting impulse control. A structural 
equation modeling framework was used to test for mediation by examining the indirect path 
from maternal IL-6 to impulse control via the newborn amygdala phenotype (see 
Supplementary Materials for details).
Results
Amygdala Volume
After adjusting for GA and scan age, higher mean maternal IL-6 was significantly associated 
with larger right amygdala volume (β=.245, p=.016; R2 change=.06; Figure 1). Mean 
maternal IL-6 was not significantly associated with left amygdala volume (β=−.023, p=.
831).
Amygdala Connectivity
Mean maternal IL-6 concentrations were significantly associated with newborn amygdala 
connectivity, with different connectivity patterns evident for the left and right amygdala. For 
the right amygdala, higher IL-6 was associated with stronger positive connectivity to right 
anterior insula (aI), fusiform gyrus/inferior temporal gyrus (ITG), caudate and thalamus. 
Higher mean IL-6 was additionally associated with stronger right amygdala connectivity to 
the left brainstem, and weaker connectivity to left superior occipital gyrus. For the left 
amygdala, higher mean IL-6 was associated with stronger connectivity to the right fusiform/
ITG, parietal/somatosensory cortex, and parahippocampal gyrus (PHG), and weaker 
connectivity to a region encompassing ITG and ventral temporal cortex (Table 3, Figure 2).
Graham et al. Page 6













Post-hoc Analyses of Potential Confounds for Maternal IL-6 Concentrations and Newborn 
Amygdala Associations
Amygdala Volume—The association between mean IL-6 and right amygdala volume 
remained significant (β=.273, p=.015) after adjusting for all of the potential confounds in the 
same model, and was not moderated by infant sex (See Supplementary Table 1). Variation in 
maternal IL-6 concentrations continued to explain approximately 6% of the variance in right 
amygdala volume (R2 change=.059).
Amygdala Connectivity—For all the identified amygdala connections, the effect of IL-6 
remained significant (p < .05) after adjusting for the potential confounds with the exception 
of right amygdala-fusiform gyrus/ITG connectivity. For this connection, the effect of IL-6 
became a trend (β=.208, p=.063), and higher pre-pregnancy BMI significantly predicted 
stronger connectivity (β=.432, p=.000). The associations between IL-6 and the right and left 
amygdala connections were not moderated by infant sex (See Supplementary Table 1).
Relevance of Amygdala Phenotypes for Impulse Control at 24-months-of-age
Amygdala Volume—Larger newborn right amygdala volume was associated with lower 
impulse control at 24 months age (β= −.261, p=.036) in the model including covariates for 
GA at birth (β=.165, p=.217), age at scan (β=.053, p=.709) and attachment security (β=.176, 
p=.228). The associated between right amygdala volume and impulse control was not 
moderated by attachment security (β=.157, p = .426). Adding maternal IL-6 concentrations 
to the model revealed no direct association with impulse control (β=.083, p=.569). However, 
larger newborn right amygdala volume mediated an association between higher maternal 
IL-6, and lower impulse control (indirect effect= −.148 ; 95% CI: −.345, −.005; based on 
5,000 bootstrap samples). Thus, higher systemic maternal IL-6 levels during pregnancy were 
associated with lower impulse control in children, via larger newborn right amygdala 
volume.
Amygdala Connectivity—The strongest right amygdala functional connection associated 
with maternal IL-6, right amygdala-aI connectivity, was not significantly associated with 
impulse control either independently or in interaction with attachment security (p > .10). The 
strongest left amygdala connection associated with IL-6, left amygdala-fusiform gyrus 
connectivity, was significantly associated with impulse control (β= −.406, p=.001) in the 
model including covariates for GA at birth (β=.093, p=.472), age at scan (β=.016, p=.904) 
and attachment security (β=.334, p=.007). Thus stronger connectivity was associated with 
lower impulse control, while a secure attachment was independently associated with better 
impulse control in this model. There was no moderated effect of attachment security (β= −.
022, p = .909). Adding maternal IL-6 to the model again revealed no direct association with 
impulse control (β=.083, p=.569). However, stronger newborn left amygdala-fusiform 
connectivity mediated an association between higher maternal IL-6, and lower impulse 
control (indirect effect= −.245 ; 95% CI: −.490, −.069; based on 5,000 bootstrap samples). 
These analyses thus identified another pathway from higher maternal IL-6 to lower impulse 
control at 24-months-of-age via stronger newborn left amygdala-fusiform connectivity.
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A growing body of research has established associations between a maternal inflammatory 
state during pregnancy and increased risk for offspring psychiatric disorders. To the best of 
our knowledge, this study provides the first evidence in humans linking a specific mediator 
of maternal inflammation, elevated maternal serum IL-6 concentrations, with the newborn 
brain. Examining the brain shortly after birth reduces potential confounding influences of 
the postnatal environment, thereby increasing capacity to differentiate pre- from postnatal 
influences on the developing brain. The findings of greater right amygdala volume and 
increased bilateral amygdala connectivity to regions involved in sensory processing and 
integration (fusiform, somatosensory cortex, thalamus), salience detection (insula), and 
learning and memory (caudate and PHG), have potential implications for offspring 
susceptibility for psychiatric disorders. Consistent with this interpretation, the newborn 
amygdala phenotypes mediated an association between higher maternal IL-6 during 
pregnancy and lower impulse control at 24 months-of-age, a behavioral phenotype 
repeatedly linked to difficulties regulating emotions and behaviors at later developmental 
stages.(57, 59–62) This provides support for a pathway from heightened maternal IL-6 
concentrations during pregnancy to an altered balance between offspring impulsivity and 
regulatory capacity through alterations in the developing amygdala.
Previous research shows that both heightened maternal cortisol during pregnancy(91), and 
high levels of stress in the early postnatal environment (92–94) are associated with increased 
amygdala volume in children. The current findings indicate an additional role for 
inflammation in shaping the developing amygdala. This is consistent with previous findings 
linking maternal inflammation during pregnancy with increased risk for offspring 
psychiatric disorders in humans,(12, 15, 53) and amplified stress reactivity and social 
deficits in animal models,(26, 42–44) phenotypes that larger amygdala volumes have been 
shown to underlie. Variation in maternal IL-6 during pregnancy explained approximately 6% 
of the variance in right amygdala volume. While this effect seems modest, it may be 
clinically meaningful, as suggested by the association with lower impulse control at 24-
months-of-age. A modest effect size at this early age is also in line with developmental 
trajectories of altered amygdala growth in relation to psychiatric disorders. For example, 
amygdala enlargement in relation to autism becomes more pronounced over early 
development with a 6% enlargement compared to typically developing controls noted at 3-
years-of-age(51, 95) and a 9–12% enlargement by 4-years-of-age.(51, 96)
Increased functional integration of the newborn amygdala with regions implicated in 
detecting and processing stimuli, determining personal relevance of stimuli, and engaging 
learning and memory systems was also observed in relation to higher maternal IL-6 
concentrations during pregnancy. The connections identified are of interest in the context of 
research in adults focused on stress responsivity and vulnerability to psychiatric disorders. 
The pattern of stronger amygdala-aI(97–99) and amygdala-caudate connectivity(100, 101) 
are in concordance with observations in adults after chronic and acute stress exposure. 
Increased strength of these connections has in turn been associated with higher perception of 
threat,(102) elevated anxiety,(103) and engagement of more rigid learning and memory 
strategies.(100, 101) Increased amygdala connectivity to brain regions involved in sensory 
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processing and integration is of interest in light of deficits in early (pre-attentive) filtering of 
sensory stimuli in psychiatric disorders linked to maternal inflammation during pregnancy.
(15) Such filtering deficits involve a network of regions including the amygdala and 
thalamus.(104, 105) Interestingly, amygdala-fusiform gyrus connectivity has been 
specifically implicated in the core and early emerging face processing deficits in autism.
(106–109)
Larger newborn amygdala volume and increased connectivity were prospectively associated 
with lower impulse control at 2-years-of-age after accounting for variation in the infant-
caregiver relationship. Amygdala activity, functional connectivity and morphology has 
previously been associated with impulse control difficulties, including risk for substance use 
disorders(110–112) and ADHD(113–117) in human adults. These associations are likely 
related to the role of the amygdala in processing salient stimuli(118–120) and anticipating 
rewards(121, 122). The specific association between stronger newborn amygdala-fusiform 
gyrus connectivity and lower impulse control may relate to the role of the amygdala in 
modulating visual processing based on salience and emotional properties of stimuli(123–
126). For example, enhanced amygdala and fusiform gyrus activity has been observed 
during visual presentation of highly salient or craved stimuli in adults(127). From a 
developmental perspective, the visual system, and specifically attentional control of vision, 
is foundational in developing cognition and emotion regulation(128, 129). It is therefore not 
surprising that coordinated functioning of the amygdala to an extrastriate visual region 
would be associated with emerging capacity to regulate response to a desired stimulus.
Whether directly mediated via placental transfer into the fetal compartment(130) or indirect 
effects mediated by placental inflammation,(39, 131) elevated maternal IL-6 concentrations 
can trigger inflammatory processes in the fetal brain, including, increased expression of IL-6 
and other cytokines.(41, 132, 133) These cytokines in the fetal brain activate Janus Kinases 
(JAKs) and associated signal transducers and activators of transcription (STAT).(134, 135) 
Activation of the JAK/STAT pathway regulates the transition from neurogenesis to 
gliogenesis.(136) Stimulation or inhibition of this pathway can lead to earlier or delayed 
onset of gliogenesis(136) and processes guided by glial cells, including neuronal migration, 
axon growth, synapse formation,(137, 138) and myelination.(139) IL-6 and other 
proinflammatory cytokines also influence developing neurotransmitter systems relevant to 
amygdala development, including effects on decreased survival of fetal serotonin neurons in 
the rostral raphe,(34) and increased expression of GABA receptors in the amygdala.(140) 
These effects of cytokines on developing neurons, glia and neurotransmitter systems suggest 
multiple potential mechanisms through which maternal inflammation during pregnancy can 
alter fetal amygdala anatomy and coordinated functioning with implications for ongoing 
behavioral and neurological development.
The findings indicate potential hemispheric differences in vulnerability to intrauterine 
inflammation. Regarding anatomy, vulnerability seemed to be greatest for the right 
amygdala, while the functional connectivity results suggest bilateral consequences of 
intrauterine inflammation, with distinct alterations for the left versus right amygdala. 
Previous work showed that elevated maternal cortisol concentrations during pregnancy were 
specifically associated with right amygdala volume.(91) Findings of larger amygdala volume 
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in association with autism at early developmental stages are also most consistent for the 
right amygdala.(51, 95, 141) With regard to connectivity, the findings for the right amygdala 
involved a slightly more extensive set of brain regions, including amygdala-aI connectivity. 
These lateralized findings are interesting in light of a potentially disproportionate role for the 
right amygdala in contributing to anxiety and processing negatively valenced stimuli,(142–
146) and for right amygdala-aI connectivity in vulnerability to stress-related disorders.(98)
Interestingly, while larger newborn right amygdala volume was associated with lower 
impulse control, right amygdala-aI connectivity was not associated with impulse control. 
This connection may be more relevant for normative and pathological variation in fear(64, 
120, 140). Although impulse control is relevant for fear and anxiety disorders, the 
associations are not straightforward.(148) The sample size of the current study makes it 
difficult to investigate interactive processes between emotionality and impulse control at 
present, but this is an important topic for future work to understand the implications of these 
newborn amygdala phenotypes for subsequent development. It should also be noted that our 
measure of impulse control does not distinguish motivation, reactivity and inhibitory control 
processes, but reflects an estimate of the balance between these components.(64) More 
nuanced investigation of these processes will also be important for advancing understanding 
of how the observed neural phenotypes relate to subsequent risk and protective factors.
Some additional limitations of the study warrant attention. First, while systemic IL-6 
represents an important marker of inflammation, we do not attribute the observed effects to 
the influence of IL-6 alone. Future research would benefit from consideration of different 
markers of inflammation, and identification of the triggers for heightened maternal 
inflammation(20, 22, 149). It will also be important to consider higher risk groups, such as 
mothers with psychiatric diagnoses, who may show distinct profiles of inflammation during 
pregnancy. We also note that while we considered a range of potential confounds, these 
variables are only considered in relation to newborn amygdala phenotypes associated with 
maternal IL-6, and are therefore not unbiased tests of the influence of these other variables 
on the newborn amygdala. This study therefore does not address the more general question 
of how these other aspects of the prenatal environment relate to the newborn amygdala. 
Finally, the present study focused on the amygdala as a starting point due to the behavioral 
phenotypes associated with maternal inflammation during pregnancy. However, given the 
ubiquitous role of cytokines in fetal brain development, identifying associations between 
maternal inflammation and multiple brain systems represents an important target of future 
research.
Despite the limitations, these results provide the first evidence to date in humans for an 
association between intrauterine inflammation, fetal brain development and emerging 
behavior. From a risk perspective, we have considered the extent to which similar amygdala 
phenotypes have been observed in psychiatric disorders. Consistent with this perspective, we 
have shown that these amygdala phenotypes are associated with lower impulse control, 
which has been linked to elevated risk for behavioral and emotional problems during 
childhood. This perspective includes a role for the postnatal environment because the 
connection between maternal inflammation and offspring psychiatric disorders is not 
deterministic,(15) and likely involves increased vulnerability to postnatal stress ("a second 
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hit").(15, 53) An adaptive, evolutionary perspective further suggests potential survival 
advantages of the observed brain phenotypes.(150) Specifically, if heightened maternal 
inflammation during pregnancy signals a more adverse, or dangerous environment, 
heightened vigilance and reactivity conferred by alterations in the amygdala could be 
adaptive depending on the match between the pre- and postnatal environment.(150–152) The 
current findings provide a foundation for ongoing investigation in this area by advancing 
understanding of the role of maternal inflammation in influencing newborn amygdala 
phenotypes and subsequent behavior.
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Refer to Web version on PubMed Central for supplementary material.
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Higher maternal IL-6 concentrations during pregnancy are associated with greater newborn 
right amygdala volume.
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Maternal IL-6 concentrations during pregnancy are associated with newborn amygdala 
functional connectivity.
Note. Mean maternal IL-6 concentrations during pregnancy are prospectively associated 
with stronger newborn right (Panel A) and left (Panel B) amygdala connectivity to several 
cortical brain regions including fusiform gyrus. Panel C shows the associations between 
higher maternal IL-6 concentrations and stronger newborn right amygdala connectivity to 
anterior insula (aI), thalamus and caudate. Panel D illustrates the association between higher 
maternal IL-6 concentrations and newborn right amygdala-aI connectivity (identified in the 
voxel-wise analyses and displayed on the brain in Panels A and C).
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Maternal Age in 1st Trimester (years) 28.2 (5.48)
Infant Age (weeks)
  Gestational Age at Birth 39.2 (1.47)
  Age at MRI Data Collection 3.79 (1.84)
Percentage
Infant Sex
  Male 59.3
  Female 40.7
Race/Ethnicity
  Caucasian non-Hispanic 37.5
  African American non-Hispanic 2.50
  Asian non-Hispanic 7.50
  Multi-racial non-Hispanic 8.75
  Caucasian Hispanic 35.0
  Asian Hispanic 1.25
  Multi-racial Hispanic 7.50
Highest Level of Maternal Education
  High-School or Test Equivalent 22.1
  Vocational School or Some
College 41.9
  Associates Degree 4.65
  Bachelors or Graduate Level
Degree 31.4
Gross Annual Household Income
  < $15,000 9.75
  $15,000 – 29,999 22.0
  $30,000 – 49,999 24.4
  $50,000 – 100,000 36.6
  > $100,000 7.32
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Table 2
Mean and standard deviation of maternal IL-6 concentrations and gestational age at collection
1st Trimester 2nd Trimester 3rd Trimester
Gestational Age 12.7 (1.71) 20.5 (1.39) 30.4 (1.33)
IL-6 Concentration (pg/ml) 0.79 (0.73) 0.98 (1.06) 1.23 (1.36)















































































































































































































































































































































Biol Psychiatry. Author manuscript; available in PMC 2019 January 15.
